Zobrazeno 1 - 10
of 190
pro vyhledávání: '"M. Chamuleau"'
Autor:
V. de Jonge, C. Duetz, W. Bruins, E. van Werkhoven, M. Nijland, K. de Heer, M. van der Poel, Y. Sandberg, C. Klerk, D. de Jong, J. Zijlstra, M. J. Kersten, T. Mutis, M. Chamuleau
Publikováno v:
HemaSphere, Vol 6, Pp 1139-1140 (2022)
Externí odkaz:
https://doaj.org/article/a00b97ab41e3434480567cf9a0a08e7e
Autor:
A. M. Spanjaart, E. Pennings, P. Mutsaers, S. van Dorp, M. Jak, J. van Doesem, J. de Boer, J. Vermaat, A. Sijs-Szabo, M. van der Poel, I. Kuipers, M. Chamuleau, I. Nijhof, M. Minnema, P. Lugtenburg, T. van Meerten, M. J. Kersten
Publikováno v:
HemaSphere, Vol 6, Pp 1344-1345 (2022)
Externí odkaz:
https://doaj.org/article/daa11f0b69a94f60b9d44ccf1204bbba
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aziza A A Adam, Vincent A van der Mark, Joanne M Donkers, Manon E Wildenberg, Ronald P J Oude Elferink, Robert A F M Chamuleau, Ruurdtje Hoekstra
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0193664 (2018)
Practice-changing culturing techniques of hepatocytes are highly required to increase their differentiation. Previously, we found that human liver cell lines HepaRG and C3A acquire higher functionality and increased mitochondrial biogenesis when cult
Externí odkaz:
https://doaj.org/article/dda135b9f4ac477fa76ca8c842d09a26
Publikováno v:
Journal of Artificial Organs
End-stage liver failure is a condition of collapsing liver function with mortality rates up to 80. Liver transplantation is the only lifesaving therapy. There is an unmet need for therapy to extend the waiting time for liver transplantation or regene
Autor:
Vincent A. van der Mark, Aziza A. A. Adam, Ronald P.J. Oude Elferink, Ruurdtje Hoekstra, Jung-Chin Chang, Robert A. F. M. Chamuleau
Publikováno v:
Toxicology and applied pharmacology, 399:115055. Academic Press Inc.
The liver cell line HepaRG is one of the preferred sources of human hepatocytes for in vitro applications. However, mitochondrial energy metabolism is relatively low, which affects hepatic functionality and sensitivity to hepatotoxins. Culturing in a
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e50952 (2012)
IntroductionAcute liver failure is a rare disease with high mortality and liver transplantation is the only life saving therapy. Accurate prognosis of ALF is crucial for proper intervention.AimTo identify and characterize newly developed prognostic m
Externí odkaz:
https://doaj.org/article/663ebd827bfa42dbb28d8d0b8f6af24f
Autor:
Geert A A Nibourg, Robert A F M Chamuleau, Tessa V van der Hoeven, Martinus A W Maas, An F C Ruiter, Wouter H Lamers, Ronald P J Oude Elferink, Thomas M van Gulik, Ruurdtje Hoekstra
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e38778 (2012)
A major roadblock to the application of bioartificial livers is the need for a human liver cell line that displays a high and broad level of hepatic functionality. The human bipotent liver progenitor cell line HepaRG is a promising candidate in this
Externí odkaz:
https://doaj.org/article/6c1861603e0d4671ab5f49e67411a5eb
Autor:
Ronald P.J. Oude Elferink, Thomas M. van Gulik, Vincent A. van der Mark, Philipp Treskes, Robert A. F. M. Chamuleau, Martien van Wenum, Aziza A. A. Adam, Aldo Jongejan, Ruurdtje Hoekstra, Perry D. Moerland
Publikováno v:
Cellular Physiology and Biochemistry, Vol 48, Iss 5, Pp 2189-2204 (2018)
Cellular physiology and biochemistry, 48(5), 2189-2204. S. Karger AG
Cellular physiology and biochemistry, 48(5), 2189-2204. S. Karger AG
Background/Aims: For applicability of cell-based therapies aimed at the treatment of liver failure, such as bioartificial livers (BALs) and hepatocyte transplantation, it is essential that the applied hepatocytes tolerate exposure to the patient plas
Autor:
Tanja Deurholt, Lysbeth Ten Bloemendaal, Aniska A. Chhatta, Albert C. W. A. Van Wijk, Kees Weijer, Jurgen Seppen, Ronald P. J. Oude Elferink, Robert A. F. M. Chamuleau, Ruurdtje Hoekstra
Publikováno v:
Cell Transplantation, Vol 15 (2006)
Mature human hepatocytes are not suitable for large-scale in vitro applications that rely on hepatocyte function, due to their limited availability and insufficient proliferation capacity in vitro. In contrast, human fetal liver cells (HFLC) can be e
Externí odkaz:
https://doaj.org/article/cb20d7667db94b94bda82a82a84d99e2